Why Mesoblast Shares Are Falling | Markets Insider

Dec 14, 2021 · Mesoblast Limited (NASDAQ: MESO) shares are trading lower after the company was notified by Novartis that it has chosen to terminate the agreement with Mesoblast prior to …

2%
OFF

Mesoblast (NASDAQ:MESO) Trading Down 2.2% - Here's Why

2 weeks from now

18 hours ago · Institutional Trading of Mesoblast. Several institutional investors have recently made changes to their positions in MESO. Signaturefd LLC boosted its holdings in Mesoblast …

marketbeat.com

4%
OFF

Mesoblast (NASDAQ:MESO) Shares Down 3.4% - MarketBeat

2 weeks from now

Jan 7, 2025 · Hedge Funds Weigh In On Mesoblast. Large investors have recently bought and sold shares of the business. Jane Street Group LLC raised its position in shares of Mesoblast …

marketbeat.com

7%
OFF

Health Check: Mesoblast Shares Sink Despite $260m Placement …

2 weeks from now

1 day ago · Mesoblast shares fall ~7% despite a $260 million placement following FDA approval for its cell therapy treatment remestemcel-L in December. ... Newfoundland, in the UK and …

stockhead.com.au

02%
OFF

Why Shares Of Mesoblast Are Down Monday | The Motley Fool

2 weeks from now

Aug 7, 2023 · Shares of Mesoblast (MESO-4.02%) were down by more than 15% as of 11:45 a.m. ET on Monday, just days after the healthcare stock plunged more than 61% on bad news …

fool.com

9%
OFF

Why Is The Mesoblast Share Price Crashing 9% Today? - The Motley …

2 weeks from now

1 day ago · The Mesoblast Ltd share price has returned from its trading halt and dropped into the red. At the time of writing, the biotech company's shares are down 9% to $2.55. Why is the …

fool.com.au

25%
OFF

Why Is The Mesoblast Share Price Sinking 25% On Tuesday?

2 weeks from now

Dec 5, 2023 · The Mesoblast Ltd share price has returned from its trading halt with a bang. In morning trade, the biotechnology company's shares are down a massive 25% to a decade-low …

fool.com.au

$2.30
OFF

Mesoblast Downgraded To Hold From Buy At Jefferies - Markets …

2 weeks from now

Dec 23, 2024 · Jefferies downgraded Mesoblast to Hold from Buy with a price target of A$2.30, up from A$1.10.The firm updated the company’s for the FDA’ss recent approval of Ryoncil in …

businessinsider.com

$20.61
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What …

2 weeks from now

Jan 3, 2025 · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $20.61, but opened at $20.10. …

marketbeat.com

57%
OFF

Mesoblast (MESO) Stock Price, News & Analysis - MarketBeat

2 weeks from now

5 days ago · 1.57% of the outstanding shares of Mesoblast have been sold short. ... Brainchip, Liontown, and Mesoblast shares are falling today. January 2, 2025 | msn.com. Why Brainchip, …

marketbeat.com

$48
OFF

Why Shares Of Mesoblast Are Plunging Friday | The Motley Fool

2 weeks from now

Aug 4, 2023 · Mesoblast only had $48.8 million in cash at the end of the quarter and reported a net loss of $18.6 million in the quarter. Jim Halley has no position in any of the stocks mentioned.

fool.com

45%
OFF

Mesoblast Limited (MESO) Loses -5.45% In 4 Weeks, Here's Why A …

2 weeks from now

Jan 5, 2024 · Mesoblast Limited (MESO) has been beaten down lately with too much selling pressure. While the stock has lost 5.5% over the past four weeks, there is light at the end of …

nasdaq.com

18%
OFF

Why The Mesoblast Share Price Is Diving 18% After An FDA Win

2 weeks from now

Dec 20, 2024 · The Mesoblast Ltd share price is taking a nosedive today. Shares in the S&P/ASX 300 Index (ASX: XKO) clinical-stage biotechnology company closed yesterday trading for $3.05.

fool.com.au

18%
OFF

Why The Mesoblast Share Price Is Diving 18% After An FDA Win - MSN

2 weeks from now

Why 29Metals, Guzman Y Gomez, Mesoblast, and Pilbara Minerals shares are falling today Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned.

msn.com

7%
OFF

Why Mesoblast, Myer, Premier Investments, And Vulcan Shares Are …

2 weeks from now

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are dropping: Mesoblast Ltd (). The Mesoblast share price is down 7% to $2.61.

msn.com

4%
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Time To Sell?

2 weeks from now

1 day ago · Jane Street Group LLC grew its stake in Mesoblast by 46.4% in the 3rd quarter. Jane Street Group LLC now owns 85,102 shares of the company's stock valued at $695,000 after …

marketbeat.com

1%
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's Why

2 weeks from now

Oct 7, 2024 · GAMMA Investing LLC grew its position in shares of Mesoblast by 50.1% in the 2nd quarter. GAMMA Investing LLC now owns 4,981 shares of the company's stock worth $34,000 …

marketbeat.com

4%
OFF

MESO News Today | Why Did Mesoblast Stock Go Down Today?

2 weeks from now

5 days ago · Jane Street Group LLC raised its stake in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) by 46.4% in the third quarter, according to the company in its …

marketbeat.com

10%
OFF

Why Are Mesoblast (MSB), Iperionx (IPX), Appen (APX), And …

2 weeks from now

1 day ago · Mesoblast Ltd . Mesoblast shares are down nearly 10% to $2.55 following the completion of a significant capital raising. The company raised A$260 million at A$2.50 per …

motiontrader.com.au

FAQs about Why Mesoblast Shares Are Falling | Markets Insider Coupon?

Is the Mesoblast share price down 75% over the last 12 months?

The Mesoblast share price is now down approximately 75% over the last 12 months. Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. ...

Is Mesoblast a profitable company?

Mesoblast has two other late-stage therapies: Revascor to treat advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. However, the company's continued difficulty in commercializing its products will likely continue to drag its shares down, especially since it isn't profitable. ...

Is Mesoblast a good stock to buy?

Mesoblast scored higher than 48% of companies evaluated by MarketBeat, and ranked 599th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Earnings and Valuation 0.6 / 5Proj. Earnings GrowthGrowing ...

Where is Mesoblast sold?

The product is sold in Japan by JCR Pharmaceuticals. Mesoblast only had $48.8 million in cash at the end of the quarter and reported a net loss of $18.6 million in the quarter. Jim Halley has no position in any of the stocks mentioned. ...

What happened to Mesoblast HQ?

With the company struggling to get its stem cell therapies approved by the US Food and Drug Administration it has continued to burn through cash like kindling in recent years. Unfortunately, this has meant it has needed to tap the market multiple times to keep the lights on at Mesoblast HQ. ...

Why did Mesoblast resubmit ryoncil?

Mesoblast focuses on therapies to treat autoimmune disorders. The company's resubmission of Ryoncil was given a Complete Response Letter by the FDA. The company will have a trial of Ryoncil on adults with host-versus-graft disease. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. ...